Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Living Cell Technologies ( (AU:1AI) ) has issued an update.
Algorae Pharmaceuticals Limited has announced a change in the interests of its director, David Hainsworth. The company, which operates in the pharmaceutical industry, focuses on developing innovative medical solutions. The announcement details the allotment of 30,000,000 performance rights to Hainsworth, as approved by shareholders at the recent AGM. This change reflects the company’s commitment to aligning its leadership’s interests with long-term strategic goals, potentially impacting its market positioning and stakeholder relations.
More about Living Cell Technologies
Average Trading Volume: 10,231,180
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$14.34M
For an in-depth examination of 1AI stock, go to TipRanks’ Overview page.